Publication | Closed Access

The infusion of ex vivo, interleukin-15 and -21-activated donor NK cells after haploidentical HCT in high-risk AML and MDS patients—a randomized trial

Cell TherapyTransplantationMarrow TransplantationStem Cell TransplantationImmunologyHematologyHaploidentical HctBlood TransplantationImmunotherapyMedicineCell TransplantationEx VivoHigh-risk Aml